Symptoms: Lymphedema.
Identifieur interne : 001785 ( Main/Exploration ); précédent : 001784; suivant : 001786Symptoms: Lymphedema.
Auteurs : Electra D. Paskett [États-Unis]Source :
- Advances in experimental medicine and biology [ 0065-2598 ] ; 2015.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Lymphoedème, Tumeurs du sein.
- tendances : Recherche biomédicale.
- étiologie : Lymphoedème.
- Facteurs de risque, Femelle, Humains, Lymphoedème, Prévention primaire, Tumeurs du sein.
English descriptors
- KwdEn :
- MESH :
- complications : Breast Neoplasms.
- diagnosis : Breast Neoplasms, Lymphedema.
- etiology : Lymphedema.
- methods : Primary Prevention.
- therapy : Breast Neoplasms, Lymphedema.
- trends : Biomedical Research.
- Female, Humans, Risk Factors.
Abstract
Lymphedema is one of the main late effects from breast cancer treatment affecting 3-60% of breast cancer survivors. Primarily occurring in the hand, arm, and/or affected breast, symptoms of lymphedema include swelling, pain, redness, restriction of arm/hand movement, tightness and feelings of fullness. These symptoms not only may limit physical functioning but also negatively affect quality of life, body image, social functioning, and financial status of breast cancer survivors with lymphedema. Unfortunately, there are no standardized methods for prevention, diagnosis, and treatment of breast cancer-related lymphedema. Despite its prevalence and lack of clinical guidelines, lymphedema is one of the most poorly understood, relatively underestimated, and least researched complications of cancer treatment. This chapter reviews the current problem of breast cancer-related lymphedema by investigating prevention and risk reduction strategies, diagnosis, and treatment. In addition, this chapter identifies future research opportunities focusing on prevention and risk reduction strategies, quality of life and physical function, surveillance, patient education, cost, diagnosis, and treatment. Challenges and recommendations for future research in these areas, particularly among underserved populations, are discussed.
DOI: 10.1007/978-3-319-16366-6_8
PubMed: 26059932
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000E40
- to stream PubMed, to step Curation: 000E40
- to stream PubMed, to step Checkpoint: 000E40
- to stream Ncbi, to step Merge: 007481
- to stream Ncbi, to step Curation: 007481
- to stream Ncbi, to step Checkpoint: 007481
- to stream Main, to step Merge: 001787
- to stream Main, to step Curation: 001785
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Symptoms: Lymphedema.</title><author><name sortKey="Paskett, Electra D" sort="Paskett, Electra D" uniqKey="Paskett E" first="Electra D" last="Paskett">Electra D. Paskett</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, USA, electra.paskett@osumc.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, USA</wicri:regionArea><wicri:noRegion>USA</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26059932</idno><idno type="pmid">26059932</idno><idno type="doi">10.1007/978-3-319-16366-6_8</idno><idno type="wicri:Area/PubMed/Corpus">000E40</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E40</idno><idno type="wicri:Area/PubMed/Curation">000E40</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E40</idno><idno type="wicri:Area/PubMed/Checkpoint">000E40</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000E40</idno><idno type="wicri:Area/Ncbi/Merge">007481</idno><idno type="wicri:Area/Ncbi/Curation">007481</idno><idno type="wicri:Area/Ncbi/Checkpoint">007481</idno><idno type="wicri:Area/Main/Merge">001787</idno><idno type="wicri:Area/Main/Curation">001785</idno><idno type="wicri:Area/Main/Exploration">001785</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Symptoms: Lymphedema.</title><author><name sortKey="Paskett, Electra D" sort="Paskett, Electra D" uniqKey="Paskett E" first="Electra D" last="Paskett">Electra D. Paskett</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, USA, electra.paskett@osumc.edu.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, USA</wicri:regionArea><wicri:noRegion>USA</wicri:noRegion></affiliation></author></analytic><series><title level="j">Advances in experimental medicine and biology</title><idno type="ISSN">0065-2598</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biomedical Research (trends)</term><term>Breast Neoplasms (complications)</term><term>Breast Neoplasms (diagnosis)</term><term>Breast Neoplasms (therapy)</term><term>Female</term><term>Humans</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (etiology)</term><term>Lymphedema (therapy)</term><term>Primary Prevention (methods)</term><term>Risk Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Lymphoedème ()</term><term>Lymphoedème (diagnostic)</term><term>Lymphoedème (étiologie)</term><term>Prévention primaire ()</term><term>Recherche biomédicale (tendances)</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (diagnostic)</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Primary Prevention</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Recherche biomédicale</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Biomedical Research</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Lymphoedème</term><term>Prévention primaire</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphedema is one of the main late effects from breast cancer treatment affecting 3-60% of breast cancer survivors. Primarily occurring in the hand, arm, and/or affected breast, symptoms of lymphedema include swelling, pain, redness, restriction of arm/hand movement, tightness and feelings of fullness. These symptoms not only may limit physical functioning but also negatively affect quality of life, body image, social functioning, and financial status of breast cancer survivors with lymphedema. Unfortunately, there are no standardized methods for prevention, diagnosis, and treatment of breast cancer-related lymphedema. Despite its prevalence and lack of clinical guidelines, lymphedema is one of the most poorly understood, relatively underestimated, and least researched complications of cancer treatment. This chapter reviews the current problem of breast cancer-related lymphedema by investigating prevention and risk reduction strategies, diagnosis, and treatment. In addition, this chapter identifies future research opportunities focusing on prevention and risk reduction strategies, quality of life and physical function, surveillance, patient education, cost, diagnosis, and treatment. Challenges and recommendations for future research in these areas, particularly among underserved populations, are discussed.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Paskett, Electra D" sort="Paskett, Electra D" uniqKey="Paskett E" first="Electra D" last="Paskett">Electra D. Paskett</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001785 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001785 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26059932
|texte= Symptoms: Lymphedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26059932" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |